Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease

BACKGROUND: Neuropsychiatric symptoms (NPS) are increasingly recognized as early non-cognitive manifestations in the Alzheimer’s disease (AD) continuum. However, the role of NPS as an early marker of pathophysiological progression in AD remains unclear. Dominantly inherited AD (DIAD) mutation carrie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Kok Pin, Pascoal, Tharick A., Mathotaarachchi, Sulantha, Chan, Yiong Huak, Jiang, Lai, Therriault, Joseph, Benedet, Andrea L., Shin, Monica, Kandiah, Nagaendran, Greenwood, Celia M. T., Rosa-Neto, Pedro, Gauthier, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780680/
https://www.ncbi.nlm.nih.gov/pubmed/33390174
http://dx.doi.org/10.1186/s40035-020-00225-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780680/
https://www.ncbi.nlm.nih.gov/pubmed/33390174
http://dx.doi.org/10.1186/s40035-020-00225-y

Ejemplares similares